Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
Medtronic
Harvard Business School
Boehringer Ingelheim
Mallinckrodt

Last Updated: June 29, 2022

Bedford Company Profile


✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for BEDFORD, and what generic and branded alternatives to BEDFORD drugs are available?

BEDFORD has twenty-nine approved drugs.

There are five tentative approvals on BEDFORD drugs.

Summary for Bedford
US Patents:0
Tradenames:22
Ingredients:19
NDAs:29

Drugs and US Patents for Bedford

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bedford METOCLOPRAMIDE HYDROCHLORIDE metoclopramide hydrochloride INJECTABLE;INJECTION 072155-001 Mar 30, 1992 DISCN No No See Plans and Pricing See Plans and Pricing
Bedford CEFTRIAXONE ceftriaxone sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 065465-004 Aug 18, 2008 DISCN No No See Plans and Pricing See Plans and Pricing
Bedford RANITIDINE HYDROCHLORIDE ranitidine hydrochloride INJECTABLE;INJECTION 074764-001 Nov 19, 2004 DISCN No No See Plans and Pricing See Plans and Pricing
Bedford METOCLOPRAMIDE HYDROCHLORIDE metoclopramide hydrochloride INJECTABLE;INJECTION 072244-001 Mar 30, 1992 DISCN No No See Plans and Pricing See Plans and Pricing
Bedford Labs AMIODARONE HYDROCHLORIDE amiodarone hydrochloride INJECTABLE;INJECTION 076299-001 Oct 24, 2002 DISCN No No See Plans and Pricing See Plans and Pricing
Bedford NEOSAR cyclophosphamide INJECTABLE;INJECTION 087442-001 Feb 16, 1982 DISCN No No See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
Express Scripts
Merck
McKesson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.